233
Views
9
CrossRef citations to date
0
Altmetric
Review

Role of sentinel lymph node biopsy in thyroid cancer

&
Pages 1429-1437 | Published online: 10 Jan 2014

References

  • Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg.127(4), 392–399 (1992).
  • Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg.220(3), 391–398 (1994).
  • Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J. Clin.56(5), 292–309 (2006).
  • Mean JH. Thyroid, Its Disease (2nd Edition). JB Lippincott, PA, USA (1948).
  • Olsen KD, DeSanto LW, Pearson BW. Positive Delphian lymph node: clinical significance in laryngeal cancer. Laryngoscope97(9), 1033–1037 (1987).
  • Resta L, Micheau C, Cimmino A. Prognostic value of the prelaryngeal node in laryngeal and hypopharyngeal carcinoma. Tumori71(4), 361–365 (1985).
  • Ferlito A, Shaha AR, Rinaldo A. Prognostic value of Delphian lymph node metastasis from laryngeal and hypopharyngeal cancer. Acta Otolaryngol.122(4), 456–457 (2002).
  • Isaacs JD, Lundgren CI, Sidhu SB, Sywak MS, Edhouse PJ, Delbridge LW. The Delphian lymph node in thyroid cancer. Ann. Surg.247(3), 477–482 (2008).
  • Morton D, Cagle L, Wong J et al. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. Presented at: Annual Meeting of the Society Surgical Oncology. Washington DC, USA, 20–22 May 1990.
  • Reintgen D, Cruse CW, Wells K et al. The orderly progression of melanoma nodal metastases. Ann. Surg.220(6), 759–767 (1994).
  • Miliotes G, Albertini J, Berman C et al. The tumor biology of melanoma nodal metastases. Am. Surg.62(1), 81–88 (1996).
  • Cabanas RM. An approach for treatment of penile carcinoma. Cancer39(2), 456–466 (1977).
  • Bilchik AJ, Giuliano A, Essner R et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J. Sci. Am.4(6), 351–358 (1998).
  • Koops HS, Doting MH, de Vries J et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother. Oncol.51(1), 1–7 (1999).
  • Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch. Surg.133(3), 288–292 (1998).
  • Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid19(11), 1167–1214 (2009).
  • Shaha AR. Management of the neck in thyroid cancer. Otolaryngol. Clin. N. Am.31(5), 823–831 (1998).
  • Carty SE, Cooper DS, Doherty GM et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid19(11), 1153–1158 (2009).
  • Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann. Surg.245(4), 604–610 (2007).
  • Roh JL, Kim JM, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann. Surg. Oncol.15(9), 2482–2486 (2008).
  • Rubello D, Pelizzo MR, Al-Nahhas A et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur. J. Surg. Oncol.32(9), 917–921 (2006).
  • Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol. Clin. N. Am.31(4), 639–655 (1998).
  • Robbins KT, Shaha AR, Medina JE et al. Consensus statement on the classification and terminology of neck dissection. Arch. Otolaryngol. Head Neck Surg.134(5), 536–538 (2008).
  • Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann. Surg. Oncol.15(4), 1177–1182 (2008).
  • Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J. Clin. Endocrinol. Metab.86(4), 1447–1463 (2001).
  • Noguchi M, Kinami S, Kinoshita K et al. Risk of bilateral cervical lymph node metastases in papillary thyroid cancer. J. Surg. Oncol.52(3), 155–159 (1993).
  • Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J. Surg.23(9), 970–973 (1999).
  • Wada N, Duh QY, Sugino K et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg.237(3), 399–407 (2003).
  • Lee J, Sung TY, Nam KH, Chung WY, Soh EY, Park CS. Is level IIb lymph node dissection always necessary in N1b papillary thyroid carcinoma patients? World J. Surg.32(5), 716–721 (2008).
  • Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch. Surg.139(1), 43–45 (2004).
  • Noguchi M, Kumaki T, Taniya T, Miyazaki I. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch. Surg.125(6), 804–806 (1990).
  • Ohshima A, Yamashita H, Noguchi S et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch. Surg.135(10), 1194–1198 (2000).
  • Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann. Surg.249(5), 840–844 (2009).
  • Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr. Relat. Cancer11(3), 571–579 (2004).
  • Albo D, Wayne JD, Hunt KK et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am. J. Surg.182(4), 393–398 (2001).
  • Montgomery LL, Thorne AC, Van Zee KJ et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth. Analg.95(2), 385–388 (2002).
  • Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J. Surg.24(11), 1396–1401 (2000).
  • Pelizzo MR, Boschin IM, Toniato A et al. The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Otolaryngol.121(3), 421–424 (2001).
  • Fukui Y, Yamakawa T, Taniki T, Numoto S, Miki H, Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer92(11), 2868–2874 (2001).
  • Orloff LA. Methylene blue and sestamibi: complementary tools for localizing parathyroids. Laryngoscope111(11 Pt 1), 1901–1904 (2001).
  • Roh JL, Park CI. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer113(7), 1527–1531 (2008).
  • Rettenbacher L, Sungler P, Gmeiner D, Kässmann H, Galvan G. Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur. J. Nucl. Med.27(9), 1399–1401 (2000).
  • Sahin M, Yapici O, Dervisoglu A et al. Evaluation of lymphatic drainage of cold thyroid nodules with intratumoral injection of Tc-99m nanocolloid. Clin. Nucl. Med.26(7), 602–605 (2001).
  • Gallowitsch HJ, Mikosch P, Kresnik E, Starlinger M, Lind P. Lymphoscintigraphy and γ probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma. Clin. Nucl. Med.24(10), 744–746 (1999).
  • Carcoforo P, Feggi L, Trasforini G et al. Use of preoperative lymphoscintigraphy and intraoperative γ-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. Eur. J. Surg. Oncol.33(9), 1075–1080 (2007).
  • Catarci M, Zaraca F, Angeloni R et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J. Surg. Oncol.77(1), 21–24 (2001).
  • Lee SK, Choi JH, Lim HI et al. Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. Eur. J. Surg. Oncol.35(9), 974–979 (2009).
  • Wiseman SM, Hick WL, Chu QD et al. Sentinel lymph node biosy in staging of differentiated thyroid cancer: a critical review. Surg. Oncol.11(3), 137–142 (2002).
  • Dzodic R, Markovic I, Inic M et al. Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J. Surg.30(5), 841–846 (2006).
  • Boschin IM, Toniato A, Piotto A et al. 99Tc nanocolloid sentinel node procedure in thyroid carcinoma. Langenbecks Arch. Surg.393(5), 705–708 (2008).
  • Takeyama H, Tabei I, Uchida K, Morikawa T. Sentinel node biopsy for follicular tumours of the thyroid gland. Br. J. Surg.96(5), 490–495 (2009).
  • Anand SM, Gologan O, Rochon L et al. The role of sentinel lymph node biopsy in differentiated thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg.135(12), 1199–1204 (2009).
  • Raijmakers PG, Paul MA, Lips P. Sentinel node detection in patients with thyroid carcinoma: a meta-analysis. World J. Surg.32(9), 1961–1967 (2008).
  • Arch-Ferrer J, Velázquez D, Fajardo R, Gamboa-Domínguez A, Herrera MF. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery130(6), 907–913 (2001).
  • Bostick PJ, Morton DL, Turner RR et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J. Clin. Oncol.17(10), 3238–3244 (1999).
  • Van Trappen PO, Gyselman VG, Lowe DG et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet357(9249), 15–20 (2001).
  • Morton DL, Hoon DS, Cochran AJ et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann. Surg.238(4), 538–549 (2003).
  • Kim J, Giuliano AE, Turner RR et al. Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma. Ann. Surg.244(5), 799–804 (2006).
  • Ahuja AT, Chow L, Chick W, King W, Metreweli C. Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin. Radiol.50(4), 229–231 (1995).
  • Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid18(4), 411–418 (2008).
  • Kouvaraki MA, Shapiro SE, Fornage BD et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery134(6), 946–954 (2003).
  • Stulak JM, Grant CS, Farley DR et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg.141(5), 489–494 (2006).
  • Roh JL, Park JY, Kim JM, Song CJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J. Surg. Oncol.99(1), 28–31 (2009).
  • Pereira JA, Jimeno J, Miquel J et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery138(6), 1095–1100 (2005).
  • Moo-Young TA, Traugott AL, Moley JF. Sporadic and familial medullary thyroid carcinoma: state of the art. Surg. Clin. North. Am.89(5), 1193–1204 (2009).
  • Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery138(6), 1152–1157 (2005).
  • Tuttle RM. Risk-adapted management of thyroid cancer. Endocr. Pract.14(6), 764–774 (2008).
  • Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual (7th Edition). Springer, NY, USA (2010).
  • Lefevre JH, Tresallet C, Leenhardt L, Jublanc C, Chigot JP, Menegaux F. Reoperative surgery for thyroid disease. Langenbecks Arch. Surg.392(6), 685–691 (2007).
  • Roh JL, Park JY, Rha KS, Park CI. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma? Head Neck29(10), 901–906 (2007).
  • White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J. Surg.31(5), 895–904 (2007).
  • Son YI, Jeong HS, Baek CH et al. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann. Surg. Oncol.15(7), 2020–2026 (2008).
  • Roh JL, Park JY, Park CI. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer115(2), 251–258 (2009).
  • Kupferman ME, Patterson DM, Mandel SJ, LiVolsi V, Weber RS. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope114(3), 403–406 (2004).
  • Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin. Oncol.14(3), 315–332 (1987).
  • Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J. Clin. Endocrinol. Metab.82(11), 3553–3562 (1997).
  • Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H. Papillary thyroid carcinoma: modified radical neck dissection improves prognosis. Arch. Surg.133(3), 276–280 (1998).
  • Zeiger MA. Evolution in the surgical management of well-differentiated thyroid cancer or not: to dissect or not dissect the central lymph node compartment. J. Surg. Oncol.101(2), 101–102 (2010).
  • Zavagno G, De Salvo GL, Scalco G et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann. Surg.247(2), 207–213 (2008).
  • Stojadinovic A, Nissan A, Protic M et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann. Surg.245(6), 846–857 (2007).
  • Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J. Natl Cancer. Inst.98(9), 599–609 (2006).
  • Liu Y, Truini C, Ariyan S. A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma. Ann. Surg. Oncol.15(9), 2412–2417 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.